4-Fluoro-2-methylaniline

We are 4-Fluoro-2-methylaniline CAS:452-71-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 4-Fluoro-2-methylaniline
Other Name: 4-Fluoro-o-toluidine;6-Amino-3-fluorotoluene;2-Amino-5-fluorotoluene;2-Methyl-4-fluoroaniline;4-Fluoro-2-methylphenylamine
CAS No: 452-71-1
MF: C7H8FN
MW: 125.14400
Density: 1.126 g/mL at 25 °C(lit.)
Boiling point: 90-92 °C16 mm Hg(lit.)
Melting point: 14ºC
Flash point: 190 °F
Refractive index: n20/D 1.537(lit.)
Vapor Pressure: 0.231mmHg at 25°C
UN Number: UN3439
UN Proper Shipping Name: NITRILES, SOLID, TOXIC, N.O.S.
Transport hazard class: 6.1
Packing group: III
 
Specification
Appearance: Light yellow transparent liquid
Purity: ≥98%
Water: ≤0.5%
 
Application: Pharmaceutical intermediates, agrochemical intermediates, dye intermediates, OLED intermediates.
Package: 25kg/drum, packed in plastic drum or plastic coated iron drum.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

4-Fluoro-2-methylaniline


Related News: Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.2-Bromo-1-(3-nitrophenyl)ethanone Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.2-cloro-3-fluoro-5-nitropiridina CAS:1079179-12-6 It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.Bromuro de [[2-ciclopropil-4- (4-fluorofenil) -3-quinolinil] metil] -trifenilfosfonio CAS:154057-58-6 Our pharma and biotech offering includes registration and commercialization of products through in-licensing and flexible partnerships.Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.

Related Products
Product Name
(S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide Cas:154127-42-1 View Details
Pyrrolo[3,​4-​c]​pyrazole, 2,​4,​5,​6-​tetrahydro-​2-​(methylsulfonyl)​-​, benzenesulfonate View Details
L-Lysine S-(carboxymethyl)-L-cysteine Cas:49673-81-6 View Details
1,3-Difluorobenzene Cas:372-18-9 manufacturer Ethyl linolenate manufacturer Momelotinib(Hcl) Cas:1380317-28-1 manufacturer Antioxidant 245 manufacturer O-(Tetrahydropyran-2-yl)-hydroxylamine Cas:6723-30-4 manufacturer